Bloomberg the Company & Products

Bloomberg Anywhere Login


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

Last $4.50 USD
Change Today -0.22 / -4.66%
Volume 80.0K
OCRX On Other Exchanges
As of 8:10 PM 03/27/15 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Linda S. Grais M.D.

Chief Executive Officer, President and Director, Ocera Therapeutics, Inc.
AgeTotal Calculated CompensationThis person is connected to 28 board members in 3 different organizations across 3 different industries.

See Board Relationships
As of Fiscal Year 2013


Dr. Linda S. Grais, also known as Lind, M.D., has been the Chief Executive Officer and President of Ocera Therapeutics Inc. since June 2012. Dr. Grais serves as a Consultant to Institute of Medicine. She served as a Partner of InterWest Partners since May 2005 and served as its Executive-in-Residence. She serves as a Venture Member of InterWest Management Partners IX, LLC and is General Partner of InterWest Partners IX, LP. She has a wide array of experience as a Physician, ...

Read Full Background

Corporate Headquarters*

525 University Avenue
Palo Alto, California 94301

United States

Phone: 650-475-0158
Fax: 650-521-5677

Board Members Memberships*

Chief Executive Officer, President and Director
Lead Independent Director, Chairman of Compensation Committee and Chairman of Nominating & Corporate Governance Committee


Yale University
Stanford University Law school
Stanford Graduate School of Business
Yale University School Of Medicine

Other Affiliations*

Annual Compensation*

Total Annual Compensation$198,802

Stock Options*

All Other Compensation$9,151
Exercisable Options73,622
Unexercisable Options491,550
Total Number of Options565,172

Total Compensation*

Total Annual Cash Compensation$292,422
Total Short Term Compensation$198,802
Other Long Term Compensation$9,151
Total Calculated Compensation$5,841,676
*Data is at least as current as the most recent Definitive Proxy.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
OCRX:US $4.50 USD -0.22


There is no Competitor Compensation data available.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact OCERA THERAPEUTICS INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at